Randomized Controlled Trial Comparing Two Different Morcellators for HoLEP Procedures

Completed · Not applicable

Conditions studied: Benign Prostatic Hypertrophy Requiring Surgical Intervention

In brief

To compare efficiency, in terms of tissue morcellation and removal time, of two commercially available FDA-approved morcellators: the VersaCut and the Piranha in subjects undergoing HoLEP procedure for benign prostatic hyperplasia (BPH).

Key facts

Study ID

NCT02195622

Run by

Indiana Kidney Stone Institute

People needed

74

Starts

2013-09-01

Expected to finish

2016-02-01

Last updated by the study team

2019-03-11

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Patients scheduled to undergo HoLEP for bladder outlet obstruction due to the prostate.
• Able to give informed consent.
• Age 18 years or older

You may not qualify if…

• • Inability to give informed consent.
• Age less than 18 years

Where it is running

• IU Health Physicians Urology — Indianapolis, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.